Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel™ in Children and Adolescents with Fragile X Syndrome (FXS) at the International Society for Autism Research Annual Meeting
- ByBenzinga-
– Data support the long-term safety and effectiveness of Zygel –– Greatest improvements seen in those with complete methylation of their FMR1 gene –DEVON, Pa., May 11, 2022...